Effect of the Home-based Digital-assisted Dyadic Tai Chi (HDTC) Training Program Among Sedentary Individuals With HF and Their Caregivers: a Randomized Controlled Trial

March 8, 2026 updated by: XIE Yao Jie Grace, The Hong Kong Polytechnic University

A Randomized Controlled Trial to Evaluate the Effect of the Home-based Digital-assisted Dyadic Tai Chi (HDTC) Training Program Among Sedentary Individuals With Heart Failure (HF) and Their Caregivers.

The full scale RCT aims to assess the effectiveness of the HDTC training program in improving functional capacity, cardiac function and secondary outcomes among sedentary chronic heart failure (CHF) individuals, while simultaneously reducing care burden and improving other outcomes for their caregivers.

Study Overview

Status

Recruiting

Conditions

Detailed Description

The full scale RCT is a two-arm parallel, single-blinded randomized controlled trial. A total of 128 CHF individuals and 128 caregivers will be enrolled and allocated to the HDTC group and the control group in a 1:1 ratio. Participants in the control group will receive usual care. Those in the HDTC group will attend usual care plus the HDTC training program, including a 30-minute educational seminar, a 1-hour dyadic coaching session, a preliminary Tai Chi training session, and 12-week Tai Chi training. Data on functional capacity, cardiac function, exercise self-efficacy, fear of activity, sedentary behavior, hospital admission, health-related quality of life, depression, anxiety, stress, and mutuality for HF individuals, as well as care burden, quality of life, depression, anxiety, stress, and mutuality of caregivers, will be collected at baseline (T0), 4 weeks (T1) and 12 weeks (T2) after the intervention. The intention-to-treat analysis (ITT), modified ITT analysis, and per-protocol analysis will be conducted. The generalized estimating equation (GEE) model will be used to measure changes in outcome variables.

Study Type

Interventional

Enrollment (Estimated)

256

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Shandong
      • Qingdao, Shandong, China, 266000
        • Recruiting
        • The Affiliated Hospital of Qingdao University
        • Principal Investigator:
          • Yao Jie Xie, PhD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • CHF individuals:

    • aged 18 to 75 years
    • diagnosed with CHF, regardless of the HF phenotype (HFrEF, HFmrEF, and HFpEF)
    • categorized as NYHA class I, II or III
    • 6MWD >150 meters (mild to moderate HF)
    • stable phase of disease in the past four weeks and capable of independently practice Tai Chi without any musculoskeletal disorders that may impede joint movement
    • sit more than 8 h/d in the past month
    • own a smartphone
    • volunteer to participate and provide informed consent.
  • caregivers:

    • age ≥18 years old
    • primary caregiver at home, who has emotional ties or social obligations with CHF individuals and provides daily care
    • able to exercise Tai Chi without help
    • volunteer to participate and provide informed consent.

Exclusion Criteria:

  • HF individuals:

    • plan to undergo surgery within the next 6 months
    • have severe comorbidities, such as cancer, liver or kidney failure, or diagnosed psychiatric disorders
    • plan to be admitted to a nursing home or other care facilities
    • regularly practice Tai Chi or engaging in other forms of exercise in the past 3 months (at least 3 times per week, at least 20 minutes of regular exercise each time)
    • currently participate in similar or related studies.
  • caregivers: · formal caregivers, such as nurses, will be excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Usual care
Participants (CHF individuals and their caregivers) in this arm will receive a 30-min online comprehensive education and nurse-led support through telephone consultations in the aspects of symptom management, medication, dietary and exercise suggestions, psychosocial support, and regular monthly follow-up.
CHF-caregiver dyads in the control group will receive the usual care, including a 30-min online comprehensive education and nurse-led support through telephone consultations in the aspects of symptom management, medication, dietary and exercise suggestions, psychosocial support, and regular monthly follow-up every month.
Experimental: HDTC training program
CHF individual and caregiver dyads in the HDTC group will receive the usual care and also the HDTC training program, including a 30-minute educational seminar, a 1-hour dyadic coaching session, a preliminary Tai Chi training session, and 12-week Tai Chi training. The 24-form Yang-style Tai Chi will be adopted.
Participants will receive usual care plus HDTC training program, including four parts: (1)30-minute educational seminar via WeChat: provide disease knowledge, propose strategies to replace sedentary behavior, and introduce Tai Chi. (2)1-hour online nurse-lead dyadic coaching session: introduce dyadic Tai Chi, clarify the roles and responsibilities, and establish a shared goal among dyads. (3)1-hour preliminary Tai Chi training session: face-to-face, introduce online Tai Chi learning, demonstrations on using heart rate monitor. (4)12-week Tai Chi training: Dyads learn Tai Chi following Tai Chi master online. The frequency gradually increased from 2 to 3 classes per week and duration extending from 30 to 50 minutes. Subsequently, they will practice Tai Chi with the master twice a week and slef-practce follow instructional videos once a week, with each session lasting 50 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
functional capacity of CHF individuals
Time Frame: From enrollment to the end of intervention at 4 weeks and 12 weeks
The six-minute walking test (6MWT) will be used to assess exercise tolerance of CHF individuals (LVEF reduced or not)
From enrollment to the end of intervention at 4 weeks and 12 weeks
cardiac function of CHF individuals
Time Frame: From enrollment to the end of intervention at 4 weeks and 12 weeks
Another primary outcome of this study is the cardiac function of those CHF individuals with HFrEF and HFmrEF, measured by LVEF. LVEF is a crucial parameter for assessing cardiac function. It is an echocardiographic measure that reflects cardiac function by indicating the percentage of blood ejected from the left ventricle with each heartbeat. Three-dimensional echocardiography will be employed to measure LVEF.
From enrollment to the end of intervention at 4 weeks and 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
care burden of caregivers
Time Frame: From enrollment to the end of intervention at 4 and 12 weeks
The Chinese version of the Zarit Caregiver Burden Interview (ZBI), will be used to measure caregivers' perceived burden of providing care.
From enrollment to the end of intervention at 4 and 12 weeks
QoL of caregivers
Time Frame: From enrollment to the end of intervention at 4 and 12 weeks
The Family Caregiver Quality of Life (FAMQOL) is a specific instrument designed by Nauser in 2011 to assess the QoL among caregivers of HF patients.
From enrollment to the end of intervention at 4 and 12 weeks
sedentary behavior of CHF individuals
Time Frame: From enrollment to the end of intervention at 4 and 12 weeks
CHF individuals' sedentary behavior will be assessed using the International Physical Activity Questionnaire-Short Form (IPAQ-SF).
From enrollment to the end of intervention at 4 and 12 weeks
Fear of Activity of CHF individuals
Time Frame: From enrollment to the end of intervention at 4 and 12 weeks
Fear of Activity in Patients with Chronic Heart Failure (Fact-CHF) will be used to assess HF patients' fear of exercise. This scale consists of 15 items, using a 5-point Likert scale where 0 represents 'never' and 4 represents 'always'. The total score ranges from 0 to 60, with higher scores indicating higher levels of fear.
From enrollment to the end of intervention at 4 and 12 weeks
Exercise self-efficacy of CHF individuals
Time Frame: From enrollment to the end of intervention at 4 and 12 weeks
Exercise self-efficacy will be assessed utilizing the Self-Efficacy for Exercise Scale (SEE) , which specifically measures an individual's confidence in performing exercise despite various barriers. The scale consists of 9 items with scores ranging from 0 to 90, with higher score indicating greater confidence in participating in exercise activities.
From enrollment to the end of intervention at 4 and 12 weeks
hospital admission of CHF individuals
Time Frame: From enrollment to the end of intervention at 12 weeks
CHF individual's hospital admission status will be presented based on the number of hospital admissions during the intervention period, including emergency visits.
From enrollment to the end of intervention at 12 weeks
Health-related QoL of CHF individuals
Time Frame: From enrollment to the end of intervention at 4 and12 weeks
Minnesota Living with Heart Failure Questionnaire (MLHFQ) is a specific and commonly used scale for measuring QoL among HF patients, which will be used to assess QoL.
From enrollment to the end of intervention at 4 and12 weeks
mutuality of CHF-caregiver dyads
Time Frame: From enrollment to the end of intervention at 4 and 12 weeks
Mutuality, is a dyadic-level variable influencing caregiver's contribution to CHF self-care, with a good relationship improving the dyadic health of both patients and caregivers. The Mutuality Scale (MS) will be used, containing 15 items categorized into four dimensions: love and affection, shared values, shared enjoyable activities, and reciprocity. Responses are rated using a 5-point Likert type (0=not at all, 4=quite a lot). The mean item score will be computed as the final score, ranging from 0 to 4, with a higher score denoting better mutuality.
From enrollment to the end of intervention at 4 and 12 weeks
depression, anxiety, and stress of CHF-caregiver dyads
Time Frame: From enrollment to the end of intervention at 4 and 12 weeks
The Depression Anxiety Stress Scales-21 (DASS-21) will be used to assess the severity of psychological distress about depression, anxiety, and stress over the preceding week of both CHF patients and their caregivers. Each of the three DASS-21 subscales contains 7 items, with a total of 21 items. A Likert scale ranging from 0 to 3 is employed, with recommended cut-off scores of 9, 7, and 14 for depression, anxiety, and stress, respectively. The higher the score, the higher the level of anxiety, depression, and stress.
From enrollment to the end of intervention at 4 and 12 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exercise self-efficacy of HF individuals
Time Frame: From enrollment to the end of intervention at 4 and 12 weeks
Exercise self-efficacy will be assessed utilizing the Self-Efficacy for Exercise Scale (SEE) , which specifically measures an individual's confidence in performing exercise despite various barriers. The scale consists of 9 items with scores ranging from 0 to 90, with higher score indicating greater confidence in participating in exercise activities.
From enrollment to the end of intervention at 4 and 12 weeks
Fear of Activity of HF individuals
Time Frame: From enrollment to the end of intervention at 4 and 12 weeks
Fear of Activity in Patients with Chronic Heart Failure (Fact-CHF) will be used to assess HF patients' fear of exercise. This scale consists of 15 items, using a 5-point Likert scale where 0 represents 'never' and 4 represents 'always'. The total score ranges from 0 to 60, with higher scores indicating higher levels of fear.
From enrollment to the end of intervention at 4 and 12 weeks
mutuality of HF-caregiver dyads
Time Frame: From enrollment to the end of intervention at 4 and 12 weeks
Mutuality, is a dyadic-level variable influencing caregiver's contribution to HF self-care, with a good relationship improving the dyadic health of both patients and caregivers. The Mutuality Scale (MS) will be used, containing 15 items categorized into four dimensions: love and affection, shared values, shared enjoyable activities, and reciprocity. Responses are rated using a 5-point Likert type (0=not at all, 4=quite a lot). The mean item score will be computed as the final score, ranging from 0 to 4, with a higher score denoting better mutuality.
From enrollment to the end of intervention at 4 and 12 weeks
depression, anxiety, and stress of HF-caregiver dyads
Time Frame: From enrollment to the end of intervention at 4 and 12 weeks
The Depression Anxiety Stress Scales-21 (DASS-21) will be used to assess the severity of psychological distress about depression, anxiety, and stress over the preceding week of both HF patients and their caregivers. Each of the three DASS-21 subscales contains 7 items, with a total of 21 items. A Likert scale ranging from 0 to 3 is employed, with recommended cut-off scores of 9, 7, and 14 for depression, anxiety, and stress, respectively. The higher the score, the higher the level of anxiety, depression, and stress.
From enrollment to the end of intervention at 4 and 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2025

Primary Completion (Estimated)

April 1, 2026

Study Completion (Estimated)

April 1, 2026

Study Registration Dates

First Submitted

March 10, 2025

First Submitted That Met QC Criteria

March 10, 2025

First Posted (Actual)

March 14, 2025

Study Record Updates

Last Update Posted (Actual)

March 11, 2026

Last Update Submitted That Met QC Criteria

March 8, 2026

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure (HF)

Clinical Trials on Usual Care Group

Subscribe